Two months have passed since the sharp correction in China's A-share market on April 7. As of June 9, over 60% of active equity funds, encompassing common stock funds, partial stock hybrid funds, balanced hybrid funds, and flexible allocation funds, have successfully regained their footing, with their net asset values returning to pre-correction levels. Notably, medical theme funds have shone brightly due to their substantial investments in innovative drugs and related sectors, vigorously contending for the title of top active equity fund in the first half of the year. In early June, the artificial intelligence (AI) industry chain, centered around computing power, began to surge, with multiple funds heavily invested in AI witnessing a significant rise in their net asset values, effectively compensating for losses incurred over the previous two months. As the mid-year mark approaches, the shifting market dynamics have emerged as a focal point of discussion.